Recent studies led by Sanford Research scientist Kamesh Surendran, Ph.D., reveal how cell to cell communication between cell types in the developing and adult kidney collecting ducts ensures the water reabsorption capacity.
A critical function of the kidney is water reabsorption, which is carried out in a highly regulated manner. In rare instances children are born with kidneys that do not reabsorb water adequately and may suffer from repeated episodes of dehydration resulting in stunted growth. Additionally, medications such as lithium, prescribed as a therapy for bipolar disorders, as a side-effect disable the kidneys water reabsorption capacity even in adults.
The Surendran Lab is focused on understanding the underlying mechanisms that determine the different cells that make up kidney collecting ducts. They recently published an article describing their work in the research journal Developmental Biology.
The different cell types of the kidney collecting ducts perform unique functions of the kidneys like regulation of water, electrolytes and pH homeostasis. When the kidney collecting ducts malfunction, it can lead to renal disease.
Findings from this study on mice, according to Dr. Surendran, could provide more information on genetic mutations that alter collecting duct cell functions and subsequently identify new human therapy options for diseases in these cells. Additionally, a better understanding of how these cells are made and maintained is essential for generating kidneys from patient-derived adult stem cells.
About 10 percent of U.S. adults, or more than 20 million people, have some degree of chronic kidney disease, the Centers for Disease Control and Prevention reports. According to Johns Hopkins University, around 1 in 500 children are born with abnormally developed kidneys due to genetic defects, which can lead to end-stage kidney disease.
Dr. Surendran sat down to talk with Sanford Health News about his history with Sanford Research and his latest work.
When it was time for me to move on from my post-doctoral training in Dr. Raphael Kopans lab at Washington University in St. Louis, Sanford Research was recruiting faculty to set up independent research programs with a focus on rare diseases. During my post-doctoral training I had stumbled on to a mouse model of the kidney disease that occurs in Alagille syndrome, a rare disease.
Professionally, I wished to set up a research program focused on how the kidney develops in order to understand and prevent what goes wrong in children born with kidney defects. Sanford Research appeared to be a great fit.
Personally, it was time for my family to move to a neighborhood with better schools as my daughter was almost ready to start kindergarten. The public school system in Sioux Falls is a blessing.
My graduate studies looking at kidney repair and regeneration made me realize that we dont really understand how the different cell types of the kidney develop. This led me to focus on understanding the genes and signals critical for normal kidney development during my post-doctoral training.
This paper on Foxi1 is the third one from my lab in a series on the topic of kidney collecting duct cell type differentiation and maintenance which we study using mouse models. The kidney collecting ducts form a branched tree-like tubular network that connects all the nephrons to the ureter and is made of two categories of cell types. Whereas we know quite a bit about the genes that regulate growth and branching of the collecting duct, we know far less about how the cells of the collecting ducts diversify and remain different to perform different specialized functions.
We previously used a novel tool which we refer to as principal cell lineage tracing mice, to prove that mature principal cells directly convert to intercalated cells, following inhibition of Notch signaling that are normally activated in principal cells by ligands expressed on neighboring intercalated cells. Interestingly, lithium treatment which is used to treat bipolar disorders also triggers principal-to-intercalated cell conversion. Patients treated with lithium tend to produce more dilute urine and develop a condition referred to as acquired nephrogenic diabetes insipidus. Since principal cells are important for water absorption to ensure sufficient hydration, this principal-to-intercalated-cell-type conversion may be part of the underlying cause of lithiums side-effect on the kidney.
In this recent paper we have identified how Notch signaling promotes principal cell fate selection during kidney development and in the process identified one way to rescue the principal cell deficiency and the urine concentrating deficiency in mice with reduced Notch signaling in the kidney collecting ducts. It remains to be determined if the kidney side-effects of lithium can be rescued by a similar mechanism.
The principal-to-intercalated-cell-type conversion in adult kidneys is a novel, unexpected finding from our previous study. We are looking into whether this cell type conversion is part of the mechanisms by which the kidney remodels its cell types in order to adapt to dietary changes such as excessive salt intake or an extremely low potassium diet. We are also examining whether certain medications prescribed to counter hypertension involve activation of Notch pathway and cell type conversion. Hence, understanding the mechanism by which Notch signal maintains the principal cells could open new ways to regulate and maintain kidney functions.
Many of the figures in this paper include confocal images which were made possible by the histology and imaging cores. Additionally, we made use of the mouse facility and metabolic cages to study the urine concentrating capacity of the mice. The ongoing work on this project is making use of the functional genomics and bioinformatics core to identify the direct targets of Hes1, and the biochemistry core to identify hes1 interacting proteins. The multitude of core facilities at Sanford Research strengthen our studies.
Malini Mukherjee, who was a post-doc in my lab and is now part of the Functional Genomics and Bioinformatics core, got to present these findings at the annual, internationally attended American Society of Nephrology (ASN) conference. It was exciting to have her abstract on this paper selected for an oral presentation at the end of 2018, which is an accomplishment in itself. Subsequently, I got invited to present a seminar on kidney collecting duct cell type differentiation and maintenance at the 2019 ASN conference. The quality and novelty of our published work has certainly been recognized within the kidney development field. What was pleasing for me is that a prominent kidney physiology researcher attended the talk and appreciated our work. This is important as our research is moving from development to maintenance which is the realm of renal physiologists.
Personally, it is fascinating to see that nature works in ways that is only limited by our imagination. Although Ive understood that mature cell types are actively maintained in a mature state, and had proposed to test if Notch signaling is required for principal cell maintenance, I had not anticipated that mature kidney epithelial cell types can switch directly from one fate to another. To top that, it may turn out that this cell type conversion is part of the way in which the kidney adapts to certain diets to perform its normal functions.
Posted In Health Care Heroes, Research
More here:
Cellular miscommunication may be root of kidney disease - Sanford Health News
- Biology of stem cells: an overview - PMC - National Center for ... - March 26th, 2024
- Iron Limitation Preserves Youthfulness of Blood Stem Cells - Mirage News - March 13th, 2024
- Mini organs grown from stem cells of unborn babies for the first time in breakthrough - The Mirror - March 9th, 2024
- The Effect of Short-Term NAD3 Supplementation on Circulating Adult Stem Cells in Healthy Individuals Aged 40-70 ... - Cureus - March 7th, 2024
- University of Liverpool Spin-Out Emerges, Pioneering Novel Adult Stem Cell-Based Therapies - India Education Diary - March 7th, 2024
- Scientists have used cells from fluid drawn during pregnancy to grow mini lungs and other organs - Yahoo News Canada - March 6th, 2024
- Japan approves new stem cell-based Alzheimer's therapy By Proactive Investors - Investing.com Australia - January 20th, 2024
- Cyberstalking pits Harvard professor against PubPeer Retraction ... - Retraction Watch - December 5th, 2023
- 10 functional health predictions for 2024, according to a doctor and ... - 1330 WFIN - December 5th, 2023
- See the Brain Like Never Before in This Gorgeous Art - Scientific American - December 5th, 2023
- Geron Announces Publication in The Lancet of Results from the ... - BioSpace - December 5th, 2023
- Stem cell injections could be the key to curing MS - Freethink - December 3rd, 2023
- Jaypirca (pirtobrutinib) Now Approved by U.S. FDA for the ... - Investors | Eli Lilly and Company - December 3rd, 2023
- Comparative Efficacy and Safety of Four JAK Inhibitors for ... - HealthDay - December 3rd, 2023
- City lights up for Francis on Anthony Nolan's birthday - Liverpool Express - December 3rd, 2023
- NOT-AR-23-022: Request for Information on Themes for the NIAMS ... - National Institutes of Health (.gov) - December 3rd, 2023
- December 2023: Intramural Papers of the Month - Environmental Factor Newsletter - December 1st, 2023
- CNA Explains: What is cord blood banking and why do parents do it? - CNA - December 1st, 2023
- Regulation of myogenesis and adipogenesis by the electromagnetic ... - Nature.com - December 1st, 2023
- The effects of vitamin K on bone health - News-Medical.Net - December 1st, 2023
- Dr Hurwitz on Ongoing Investigations of the Use of CAR T-Cell ... - OncLive - December 1st, 2023
- Mitophagy in human health, ageing and disease - Nature.com - December 1st, 2023
- Adult Stem Cells - Stem Cells and the Future of Regenerative Medicine ... - November 29th, 2023
- Navigating The Regulatory Landscape Of Longevity Health Products ... - Mondaq News Alerts - November 29th, 2023
- MS breakthrough could lead to treatments that halt disease's ... - inews - November 29th, 2023
- Reprogramming tissue mechanically to promote wound healing - Phys.org - November 29th, 2023
- Latest Advances in Arthritis Diagnosis and Treatment at American ... - HealthDay - November 29th, 2023
- Sex-associated differences in frequencies and prognostic impact of ... - Nature.com - November 29th, 2023
- Hematologists Dive into the Current Treatment Landscape - OncLive - November 29th, 2023
- Team discovers protein crucial for B cell differentiation and antibodies - Phys.org - November 29th, 2023
- Science Talk - I survived cancer as a child and now I'm working to ... - The Institute of Cancer Research - November 29th, 2023
- First Edition: Nov. 29, 2023 - KFF Health News - November 29th, 2023
- Symptoms: Unilateral Hearing Loss and Tinnitus : The Hearing Journal - LWW Journals - November 29th, 2023
- Mitigation of sepsis-induced acute lung injury by BMSCs | IJN - Dove Medical Press - November 29th, 2023
- A Case of a Constricted Vessel: The Impact of Acute Myeloid ... - Cureus - November 29th, 2023
- Mum brushed off fatigue after having baby but fall sparked deadly diagnosis - The Mirror - November 29th, 2023
- How heritable is the epigenome? - Drug Discovery News - November 29th, 2023
- The Blueprint of Regeneration: Scientists Discover How to Turn Stem Cells Fate - Revyuh - November 27th, 2023
- BrainStorm Cell Therapeutics Announces In-Person Meeting with ... - Marketscreener.com - November 27th, 2023
- Stem Cell Therapy Developed in Korea Begins Treatment for ... - PharmiWeb.com - November 25th, 2023
- COVID-19 Pandemic's Adverse Effect on Bone Health in Young ... - HealthDay - November 25th, 2023
- Sickle cell breakthrough - The Indian Express - November 25th, 2023
- Wall thickness analysis method for judging the degree of lower ... - Nature.com - November 25th, 2023
- Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference - Yahoo Finance - November 23rd, 2023
- Disease Transmission and Diagnosis of Zika Virus - Cureus - November 23rd, 2023
- Gene-editing therapy for sickle cell earns conditional approval in UK - Sickle Cell Disease News - November 23rd, 2023
- Stem Cell Therapy Developed in Korea Begins Treatment for ... - Newswire - November 21st, 2023
- Efficacy of ADSC-CM in Patients with Telogen Effluvium | SCCAA - Dove Medical Press - November 21st, 2023
- BrainStorm Cell Therapeutics Announces In-Person Meeting with ... - PR Newswire - November 21st, 2023
- The Impact of CAR T Cell Therapy on Managing R/R LBCL - OncLive - November 21st, 2023
- Mansour bin Zayed witnesses inauguration of ADSCC Bone Marrow Transplant & Cellular Therapy Congress 2023 - ZAWYA - November 21st, 2023
- Listeria: Who is most susceptible? What are the Symptoms? What ... - Food Poison Journal - November 21st, 2023
- Scope Of Issued Patents May Be Limited By Prosecution Estoppel ... - Mondaq News Alerts - November 21st, 2023
- Qrons Announces the Addition of Professor Shiri Navon-Venezia to ... - StreetInsider.com - November 21st, 2023
- Financially strapped Athersys raises $10.4M - cleveland.com - November 19th, 2023
- From the India Today archives (2010) | How stem cells can save your life - India Today - November 19th, 2023
- Inactivation of the tumor suppressor gene Apc synergizes with H ... - Science - November 19th, 2023
- The Origins of Multiple Myeloma and Why it Matters - HealthTree For AML - Acute Myeloid Leukemia - November 19th, 2023
- Treatment Considerations With TROP2-Targeted Therapy - OncLive - November 19th, 2023
- Athersys narrows loss, raises $10.4 million during third quarter to ... - The Business Journals - November 17th, 2023
- Who was Dolly the Sheep and what happened to her? The story of ... - BBC Countryfile Magazine - November 17th, 2023
- UK first to approve CRISPR treatment for diseases: what you need to ... - Nature.com - November 17th, 2023
- 1st sickle cell patient to be given therapy restoring fetal hemoglobin - Sickle Cell Disease News - November 15th, 2023
- Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates - Century - Benzinga - November 13th, 2023
- Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer - Yahoo Finance - November 11th, 2023
- Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in... - November 11th, 2023
- AAO 2023: Paul Runge and his ROP treatments in the Ukraine - Modern Retina - November 11th, 2023
- The Evolutionary Reasons We Are Drawn To Horror Movies and ... - Slashdot - November 11th, 2023
- Century Therapeutics Reports Third Quarter 2023 Financial Results ... - GlobeNewswire - November 11th, 2023
- Century Therapeutics Reports Third Quarter 2023 Financial Results ... - StreetInsider.com - November 9th, 2023
- NYU Langone Health Performs World's First Whole-Eye & Partial ... - NYU Langone Health - November 9th, 2023
- BrainStorm to Announce Third Quarter 2023 Financial Results and ... - BioSpace - November 9th, 2023
- Can we cut cost and pain of IVF? Start-up CEO tries out own ... - Genetic Literacy Project - November 9th, 2023
- Jasper Therapeutics Reports Third Quarter 2023 Financial Results ... - BioSpace - November 9th, 2023
- Impaired neural stress resistance and loss of REST in bipolar ... - Nature.com - November 9th, 2023
- Functional genomics and systems biology in human neuroscience - Nature.com - November 9th, 2023
- Trial launched to test CAR T-cell therapy in dogs diagnosed with ... - EurekAlert - November 9th, 2023
- The-Gut's-Lasting-Impact-on-Severe-COVID-19-Immune-Response - Infectious Disease Special Edition - November 9th, 2023
- Emerging Cure for Sickle Cell on its Way to FDA Approval, Carries ... - Dallasweekly - November 7th, 2023
- The science works, but will we pay for it? - Irish Medical Times - November 7th, 2023
Recent Comments